Article
Version 1
Preserved in Portico This version is not peer-reviewed
Aluminum Adjuvants and Childhood Disease Prevalence
Version 1
: Received: 22 February 2024 / Approved: 28 February 2024 / Online: 28 February 2024 (08:00:30 CET)
How to cite: Mokeddem, K. Aluminum Adjuvants and Childhood Disease Prevalence. Preprints 2024, 2024021613. https://doi.org/10.20944/preprints202402.1613.v1 Mokeddem, K. Aluminum Adjuvants and Childhood Disease Prevalence. Preprints 2024, 2024021613. https://doi.org/10.20944/preprints202402.1613.v1
Abstract
This study investigated the relationship between aluminum adjuvant vaccines and the prevalence of 4 childhood diseases (Autism, Allergies, Asthma, ADD/ADHD) using data from the 2020-2021 National Survey of Children's Health (NSCH) [1] and the Centers for Disease Control National Immunization Survey (CDC NIS) [2]. The study found an association with aluminum adjuvant dosage and the prevalence of each disease studied (Autism, Allergies, Asthma, ADD/ADHD) through a weighted regression analysis of disease prevalence against the summed likelihood of aluminum adjuvant vaccine uptake.
Keywords
Aluminum Adjuvants; NSCH; NIS-Child
Subject
Medicine and Pharmacology, Epidemiology and Infectious Diseases
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment